Charles Chon

Charles Chon is Partner and Managing Director of Ally Bridge Group, a global healthcare investment fund based in Hong Kong. Mr. Chon leads ABG’s effort in Medical Technologies and Pharmaceuticals, and is a member of ABG’s Investment Committee. He has nearly two decades of healthcare investing and business strategy experience. Before joining ABG, Mr. Chon was a healthcare public equity research analyst for over 13 years on both the buy-side and sell-side, mostly as a senior equity research analyst at Goldman Sachs on the US medical devices team. From there, Mr. Chon became the Sector Head for US medical devices research at Stifel Nicolaus. Mr. Chon began his career on Wall Street at ABN AMRO and also covered the healthcare sector from the buy-side at Fred Alger Management. Mr. Chon holds the CFA designation, and received his MBA (healthcare management) from Boston University and BA (Chemistry) from Amherst College.